Ethionamide
Back to searchMolecule Structure
Scientific Name
Ethionamide
Description of the Drug
Ethionamide is a second line antitubercular agent used to treat tuberculosis when other treatments have failed.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00609
http://www.drugbank.ca/drugs/DB00609
Brand Name(s)
Trecator, Trecator-sc
Company Owner(s)
Wyeth Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Enoyl-[acyl-carrier-protein] reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL1849 |
Clinical Trial(s)
Unichem Links
| Atlas | ethionamide | |
| SureChEMBL | SCHEMBL27007 | |
| PharmGKB | PA164768738 | |
| Human Metabolome Database | HMDB0014747 | |
| DrugBank | DB00609 | |
| PubChem: Thomson Pharma | 15413224 | |
| PubChem | 2761171 | |
| Mcule | MCULE-1322319906 | |
| NMRShiftDB | 20208897 | |
| LINCS | LSM-5620 | |
| Nikkaji | J2.066D | |
| PDBe | 1JA | |
| BindingDB | 50239976 | |
| EPA CompTox Dashboard | DTXSID0020577 | |
| DrugCentral | 1083 | |
| Brenda | 156877 | 2142 |
| Rhea | 4885 | |
| ChemicalBook | CB1292374 | |
| rxnorm | TRECATOR | ETHIONAMIDE |
| PubChem: Drugs of the Future | 92309393 | |
| KEGG Ligand | C07665 | |
| ChEBI | 4885 | |
| ZINC | ZINC000003872520 |
